Investing.com - Collplant ADR reported on Thursday first quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Collplant ADR announced earnings per share of $0.16 on revenue of $15.64M. Analysts polled by Investing.com anticipated EPS of $-0.26 on revenue of $338K.
Collplant ADR shares are down 24.33% from the beginning of the year and are trading at $12.38 , down-from-52-week-high.They are under-performing the Nasdaq which is down 11.01% from the start of the year.
Collplant ADR follows other major Healthcare sector earnings this month
Collplant ADR's report follows an earnings missed by Merck ADR on Thursday, March 3, 2022, who reported EPS of $0.4558 on revenue of $5.77B, compared to forecasts EPS of $0.4818 on revenue of $5.88B.
Moderna had beat expectations on Thursday, February 24, 2022 with fourth quarter EPS of $11.29 on revenue of $7.21B, compared to forecast for EPS of $9.96 on revenue of $6.8B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar